USD10
GUTS Shares
About Fractyl HealthFractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.
USD10
GUTS Shares
About Fractyl HealthFractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$111.94M
OPEN PRICE
$0.697
LOW (1Y)
$0.3772
HIGH (1Y)
$2.45
LOW (24H)
$0.69
HIGH (24H)
$0.7199
VOLUME (24H)
$1.06M
38.08%
Price history
Time | Price | Change |
|---|---|---|
Today | $0.697 | |
1 Day | $0.6969 | |
1 Week | $0.69 | |
1 Month | $0.818 | |
1 Year | $0.977 |
Past performance is not a reliable indicator of future results.
Discover more
Popular prediction markets
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.